Michael Swartzburg

Michael Swartzburg has an extensive background in finance and executive leadership within the biotechnology and healthcare industry. Michael currently serves as the Chief Financial Officer at Dermavant Sciences, overseeing various departments including accounting, finance, and investor relations. With over 20 years of experience, Michael has held key positions in companies such as Iovance Biotherapeutics, Pharmozyme Incorporated, and iClinCloud. Michael has a Bachelor's degree in Business Administration with a focus on Accounting from California State University, Northridge, and a Master of Business Administration from the University of Phoenix.